Modular Medical (NASDAQ:MODD) Posts Earnings Results, Misses Expectations By $0.01 EPS

Modular Medical (NASDAQ:MODD) posted its earnings results on Thursday. The company reported ($0.13) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.12) by ($0.01), Zacks reports.

Modular Medical Stock Performance

NASDAQ:MODD traded down $0.02 during midday trading on Friday, reaching $1.14. 63,548 shares of the stock traded hands, compared to its average volume of 68,656. The stock has a market capitalization of $46.16 million, a PE ratio of -1.80 and a beta of 0.51. Modular Medical has a 12-month low of $1.10 and a 12-month high of $2.65. The business has a 50-day moving average of $1.36 and a two-hundred day moving average of $1.77.

Insiders Place Their Bets

In other Modular Medical news, Director Manchester Management Co Llc purchased 21,000 shares of the stock in a transaction on Tuesday, December 3rd. The stock was acquired at an average price of $1.68 per share, with a total value of $35,280.00. Following the completion of the acquisition, the director now owns 265,750 shares in the company, valued at $446,460. The trade was a 8.58 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through this link. Over the last three months, insiders have bought 287,666 shares of company stock valued at $454,279. 20.46% of the stock is currently owned by insiders.

About Modular Medical

Modular Medical, Inc operates as a medical device company. It focuses on the design, development, and commercialization of insulin pumps. It offers MODD1, a two-part patch pump for type-1 and type-2 diabetes. The company is headquartered in San Diego, California.